Best Practice & Research Clinical Rheumatology
Volume 23, Issue 3 , Pages 429-443 , June 2009

Recent developments in the classification and assessment of vasculitis

  • Richard A. Watts, DM, FRCP (Clinical Senior Lecturer)

      Affiliations

    • School of Medicine, Health Policy and Practice, University of East Anglia, Norwich NR4 7TJ, UK
    • Corresponding Author InformationCorresponding author.
    • ,
  • David G.I. Scott, MD, FRCP (Consultant Rheumatologist)

      Affiliations

    • Department of Rheumatology, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK

References 

  1. Kussmaul AMK. Uber eine nicht bisher beschriebene eigenthumliche Arterienerkrankung (Periarteritis nodosa), die mit Morbus Brightii und rapid fortschreitender allgemeiner Muskelahmung einhergeht. Deutsche Archiv Klinische Medizin. 1866;1:484–518
  2. Matteson EL. A history of early investigation in polyarteritis nodosa. Arthritis Care Res. 1999;12(4):294–302
  3. Zeek PM. Periarteritis nodosa; a critical review. Am J Clin Pathol. 1952;22(8):777–790
  4. Davson JBJ, Platt R. The kidney in periarteritis nodosa. Q J Med. 1948;17:175–202
  5. Fries JF, Hunder GG, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum. 1990;33(8):1135–1136
  6. Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33(8):1129–1134
  7. Bloch DA, Michel BA, Hunder GG, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods. Arthritis Rheum. 1990;33(8):1068–1073
  8. Calabrese LH, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum. 1990;33(8):1108–1113
  9. Hunder GG, Arend WP, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum. 1990;33(8):1065–1067
  10. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33(8):1122–1128
  11. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990;33(8):1101–1107
  12. Lightfoot RW, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 1990;33(8):1088–1093
  13. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33(8):1094–1100
  14. Mills JA, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum. 1990;33(8):1114–1121
  15. Rao JK, Allen NB, Pincus T. Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Ann Intern Med. 1998;129(5):345–352
  16. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37(2):187–192
  17. Hagen EC, Daha MR, Hermans J, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA assay standardization. Kidney Int. 1998;53(3):743–753
  18. Sorensen SF, Slot O, Tvede N, Petersen J. A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature. Ann Rheum Dis. 2000;59(6):478–482
  19. Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003;349(1):36–44
  20. Lane SE, Watts RA, Barker TH, Scott DG. Evaluation of the Sorensen diagnostic criteria in the classification of systemic vasculitis. Rheumatology (Oxford). 2002;41(10):1138–1141
  21. Reid AJ, Harrison BD, Watts RA, et al. Churg-Strauss syndrome in a district hospital. QJM. 1998;91(3):219–229
  22. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore). 1984;63(2):65–81
  23. Lane SE, Watts RA, Shepstone L, Scott DG. Primary systemic vasculitis: clinical features and mortality. Qjm. 2005;98(2):97–111
  24. Watts R, Lane S, Hanslik T, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 2007;66:222–227
  25. Guillevin L, Pagnoux C, Teixera L. Polyarteritis Nodosa. Vasculitis. In:  Bridges L,  Ball G editor. 2nd edn.. Oxford: Oxford University Press; 2008;p. 335–353
  26. Liu LJ, Chen M, Yu F, et al. Evaluation of a new algorithm in classification of systemic vasculitis. Rheumatology (Oxford). 2008;47(5):708–712
  27. Watts RA, Scott DG, Jayne DR, et al. Renal vasculitis in Japan and the UK – are there differences in epidemiology and clinical phenotype?. Nephrol Dial Transplant. 2008;23(12):3928–3931
  28. Henegar C, Pagnoux C, Puechal X, et al. A paradigm of diagnostic criteria for polyarteritis nodosa: analysis of a series of 949 patients with vasculitides. Arthritis Rheum. 2008;58(5):1528–1538
  29. Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65(7):936–941
  30. Committee JKDR. Diagnostic Guidelines for Kawasaki Disease. 2002 5th edn. Tokyo.
  31. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004;114(6):1708–1733
  32. Ozen S, Anton J, Arisoy N, et al. Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr. 2004;145(4):517–522
  33. Luqmani RA, Bacon PA, Moots RJ, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM. 1994;87(11):671–678
  34. Luqmani RA, Exley AR, Kitas GD, Bacon PA. Disease assessment and management of the vasculitides. Baillieres Clin Rheumatol. 1997;11(2):423–446
  35. Flossmann O, Bacon P, de Groot K, et al. Development of comprehensive disease assessment in systemic vasculitis. Ann Rheum Dis. 2007;66(3):283–292
  36. de Groot K, Gross WL, Herlyn K, Reinhold-Keller E. Development and validation of a disease extent index for Wegener's granulomatosis. Clin Nephrol. 2001;55(1):31–38
  37. Stone JH, Hoffman GS, Merkel PA, et al. A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum. 2001;44(4):912–920
  38. Mahr AD, Neogi T, Lavalley MP, et al. Assessment of the item selection and weighting in the Birmingham vasculitis activity score for Wegener's granulomatosis. Arthritis Rheum. 2008;59(6):884–891
  39. Merkel PA, Seo P, Aries P, et al. Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7. J Rheumatol. 2005;32(12):2488–2495
  40. Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore). 1996;75(1):17–28
  41. Misra RD, Jayaseelan D, Sivakumar L, et al. ITAS and DEI.TAK - Scores for clinical disease activity and damage extent in Takayasu aorto-arteritis. Rheumatology (Oxford). 2008;47:ii101
  42. Exley AR, Bacon PA, Luqmani RA, et al. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum. 1997;40(2):371–380
  43. Exley AR, Carruthers DM, Luqmani RA, et al. Damage occurs early in systemic vasculitis and is an index of outcome. QJM. 1997;90(6):391–399
  44. Seo P, Luqmani RA, Flossmann O, et al. The future of damage assessment in vasculitis. J Rheumatol. 2007;34(6):1357–1371
  45. Koutantji M, Harrold E, Lane SE, et al. Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis. Arthritis Rheum. 2003;49(6):826–837
  46. Nataraja A, Mukhtyar C, Helmich B, et al. Outpatient assessment of systemic vasculitis. Best Pract Res Clin Rheumatol. 2007;21:713–732

PII: S1521-6942(08)00154-X

doi: 10.1016/j.berh.2008.12.004

Best Practice & Research Clinical Rheumatology
Volume 23, Issue 3 , Pages 429-443 , June 2009

Article Tools

* Image Usage & Resolution